TCRT icon

Alaunos Therapeutics

133 hedge funds and large institutions have $171M invested in Alaunos Therapeutics in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership:

25% less capital invested

Capital invested by funds: $228M → $171M (-$56.5M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

63% less call options, than puts

Call options by funds: $1.39M | Put options by funds: $3.75M

Holders
133
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.39M
Puts
$3.75M
Net Calls
Net Calls Change

Top Sellers

1 -$5.04M
2 -$1.14M
3 -$1M
4
Renaissance Technologies
Renaissance Technologies
New York
-$942K
5
Norges Bank
Norges Bank
Norway
-$816K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$669K
27
$661K
28
$608K
29
$575K
30
$574K
31
$491K
32
$450K
33
$426K
34
$389K
35
$389K
36
$381K
37
$356K
38
$338K
39
$335K
40
$317K
41
$306K
42
$302K
43
$301K
44
$263K
45
$259K
46
$234K
47
$230K
48
$218K
49
$213K
50
$204K